Khurshed, M.; Prades-Sagarra, E.; Saleh, S.; Sminia, P.; Wilmink, J.W.; Molenaar, R.J.; Crezee, H.; van Noorden, C.J.F.
Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells. Cancers 2022, 14, 6228.
https://doi.org/10.3390/cancers14246228
AMA Style
Khurshed M, Prades-Sagarra E, Saleh S, Sminia P, Wilmink JW, Molenaar RJ, Crezee H, van Noorden CJF.
Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells. Cancers. 2022; 14(24):6228.
https://doi.org/10.3390/cancers14246228
Chicago/Turabian Style
Khurshed, Mohammed, Elia Prades-Sagarra, Sarah Saleh, Peter Sminia, Johanna W. Wilmink, Remco J. Molenaar, Hans Crezee, and Cornelis J. F. van Noorden.
2022. "Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells" Cancers 14, no. 24: 6228.
https://doi.org/10.3390/cancers14246228
APA Style
Khurshed, M., Prades-Sagarra, E., Saleh, S., Sminia, P., Wilmink, J. W., Molenaar, R. J., Crezee, H., & van Noorden, C. J. F.
(2022). Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells. Cancers, 14(24), 6228.
https://doi.org/10.3390/cancers14246228